Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP: CBIH )

0.0013 -0.0004 (-23.53%)
Streaming Delayed Price Updated: 2:09 PM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 79,835,035
Open 0.0019
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0017
Today's Range 0.0012 - 0.0020
52wk Range 0.0003 - 0.0018
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Texas Cannabis Company Secures $2B Valuation From LA Financial Firm
Texas cannabis research firm CBIH secures $2 billion valuation after strategic revamp. Valuation fuels growth plans. Read now! 
Via Benzinga
Topics Cannabis
Exposures Cannabis
CBIH Achieves $2 Billion Valuation Following StoneBridge Advisory Assessment
Houston, Texas--(Newsfile Corp. - June 17, 2024) - Cannabis Bioscience International Holdings (OTC PINK: CBIH) has been valued at $2... 
Via Newsfile
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property

Performance

YTD
+62.50%
+62.50%
1 Month
+85.71%
+85.71%
3 Month
+30.00%
+30.00%
6 Month
+62.50%
+62.50%
1 Year
+160.00%
+160.00%

More News

Read More
Vita Biotech Retains CBIH Services for Clinical Studies
Via Newsfile
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
Executive Changes In Marijuana Industry You Should Know About, New Cannabis Appointments & More
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Bioscience International Holdings Engages StoneBridge Advisory for Comprehensive Company Valuation
Via Newsfile
Topics Cannabis
Exposures Cannabis
CBIH Engages Prestigious Law Firm for its First Patent Applications
Via Newsfile
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
CBIH Welcomes New Treasurer and Director, Mr. John E. Jones
Via Newsfile
Topics Cannabis
Exposures Cannabis
Who's Who In Cannabis: Latest Executive Changes You Should Know About
Via Benzinga
CBIH Commences Clinical Trials of Osteoarthritis Injection "Orthocann"
Via Newsfile
Topics Cannabis
Exposures Cannabis
CBIH Announces the Retirement of One Billion Shares
Via Newsfile
Topics Artificial Intelligence Cannabis Retirement
Exposures Artificial Intelligence Cannabis Pension
Brian Cuban Joins Cannabis Bioscience International Holdings as an Advisory Board Member
Via Newsfile
Topics Cannabis
Exposures Cannabis
Cannabis Bioscience International Holdings, Inc. Announces Engagement of Bull in Advantage as its Investor Relations Firm
Via Newsfile
Topics Cannabis ETFs
Exposures Cannabis
A Letter From Cannabis Bioscience International Holdings CEO Dante Picazo Regarding Actual Progress and Plans for 2024
Via Newsfile
Topics Cannabis
Exposures Cannabis
SEC Green Lights Public Listing Of Texas Cannabis Co. That Will Use AI In Clinical Trials
Via Benzinga
Topics Artificial Intelligence Cannabis Regulatory Compliance
Exposures Artificial Intelligence Cannabis Legal
Texas Has Given Birth to Its First and Only Global Publicly Traded Cannabis Company, Cannabis Bioscience International Holdings
Via Newsfile
Topics Cannabis
Exposures Cannabis
Cannabis Bioscience International Holdings Announces Effectiveness of Form S-1 Registration Statement
Via NewMediaWire
Topics Cannabis Regulatory Compliance
Exposures Cannabis Legal Regulatory
Cannabis Bioscience International Holdings (CBIH) Unveils Its Rebranding Through Its New and Innovative Website
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
FINRA Announces Approval for Corporate Name Change From China Infrastructure Construction Corp. to Cannabis Bioscience International Holdings and Ticker Symbol Change from CHNC to CBIH
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.